Detailed explanation of the functions, efficacy and clinical application of everolimus (Afinitor)

Everolimus (Everolimus) is an oral rapamycin (mTOR) inhibitor. It inhibits the mTORC1 signaling pathway and blocks tumor cell proliferation, angiogenesis and metabolic activities, thereby exerting anti-tumor effects. At the same time, it also has certain immunomodulatory functions and can be used to prevent rejection after organ transplantation. The targeting properties of everolimus determine its clinical value in tumor treatment and immune-related diseases.

Everolimus is widely used in the treatment of a variety of diseases, including solid tumors such as advanced renal cell carcinoma, breast cancer, and pancreatic neuroendocrine tumors. In organ transplantation, it can effectively prevent rejection and maintain stable function of transplanted organs. In addition, everolimus has also shown good efficacy in patients with tuberous sclerosis (TSC)-related kidney tumors or cerebral hemangiomas. The advantage of its oral administration makes patient compliance better.

Clinical studies have shown that everolimus can delay tumor progression, improve patients' progression-free survival (PFS), and improve quality of life. In organ transplant patients, everolimus can significantly reduce the incidence of acute rejection. Its efficacy is affected by factors such as the patient's underlying disease, combined medication regimen, and dose adjustment. Therefore, clinical use requires individualized design to achieve the best therapeutic effect.

During the use of everolimus, attention should be paid to the risk of infection related to immunosuppression, abnormal blood sugar and blood lipids, and changes in liver and kidney function. Patients should regularly monitor blood routine, liver and kidney function and metabolic indicators, and adjust the dose if necessary. At the same time, avoid co-administration with potent CYP3A4 inhibitors or inducers to prevent drug concentration fluctuations from affecting efficacy. Following doctor's guidance, scientific monitoring and lifestyle management can achieve the best clinical effect of everolimus while ensuring safety.

Reference link:https://www.drugs.com